Alzheimer’s disease target and drug discovery by leveraging multiomics and electronic health data
Study limitation reported by the research below: “The EPHX2 mouse model used is 5xFAD, which has high amyloid overexpression and may not fully represent the complexity of human AD; cognitive benefit in mice does not guarantee clinical efficacy.”